Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson tRACLEER (bosentan) [reported separately through FY2019Q4] — Worldwide reported growth YoY (%) (%)
Form 8-K EX-99.2 Segment Sales Schedule
Latest, Q2 2019
-28.0%
Period ended Jun 30, 2019
Change on a year earlier
–
History
4 quarters
Since Q3 2018
Sources
4
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | TRACLEER (bosentan) [reported separately through FY2019Q4] — Worldwide reported growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q2 2019 | Jun 30, 2019 | -28.0% | – | Form 8-K (a2019q2exhibit9915.htm, filed 2019-07-16) ↗ |
| Q1 2019 | Mar 31, 2019 | -16.7% | – | Form 8-K (a2019q1exhibit9915.htm, filed 2019-04-16) ↗ |
| Q4 2018 | Dec 30, 2018 | -25.7% | – | Form 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗ |
| Q3 2018 | Sep 30, 2018 | -33.8% | – | Form 8-K (a8k2018q3exhibit9915.htm, filed 2018-10-16) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson TRACLEER (bosentan) [reported separately through FY2019Q4] — Worldwide reported growth YoY (%) (%), quarterly Q3 2018–Q2 2019 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/drug_tracleer_rep_yoy
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.